Albeena Nisar
Scientific, Car T Cell Therapy Centre & cGMP Cell Therapy Unit Project Officer Tata Memorial Centre
Albeena Nisar is a scientific officer at the CAR T Cell Therapy Centre and cGMP Cell Therapy Unit at ACTREC, where she leads projects on CAR T cell therapies and oncolytic virotherapy for resistant cancers. She also serves as a DBT BioCare Scientist and Principal Investigator, focusing on the design and development of novel indigenous oncolytic vectors for therapeutically resistant breast cancer.
Previously, Albeena held leadership roles at TATA Memorial Hospital, overseeing CAR T and cell therapy manufacturing, R&D, analytics, and facility operations. She has conducted postdoctoral research at ICMR-NIRRH on preclinical testing of anti-infertility vaccines and held academic positions at the University of Kashmir.
Albeena earned her PhD and MPhil in Biochemistry from the University of Kashmir in collaboration with CSIR-Indian Institute of Integrative Medicine, and a Master’s degree in Clinical Biochemistry from the University of Kashmir. Her early research experience includes projects at AIIMS and Sher-i-Kashmir Institute of Medical Sciences on innate immunity, immunological techniques, and clinical biochemistry.
Seminars
- Share how regulators in Europe, the US, and Asia are adapting frameworks to keep pace with emerging cell and gene therapy technologies
- Highlight initiatives that foster earlier and more constructive engagement
- Understand how modernisation efforts can accelerate approvals, support broader adoption, and make CGTs more commercially viable
- Examine key challenges in developing CAR-TCR therapies from bench to bedside in low- and middle-income countries, from infrastructure to funding gaps
- Share practical solutions to reduce costs, strengthen local manufacturing capacity, and accelerate clinical translation
- Present clinical data showcasing progress and potential for scalable, sustainable innovation in LMIC settings
